-
Regulatory tracker: Agios awaits FDA decision as target date passes
02 Jul 2025 21:48 GMT
… Excellence (NICE) has cleared Alnylam’s blockbuster Amvuttra for use … is a new oral antibiotic that can be used … Gepotidacin, a first-in-class antibiotic, scored its original FDA approval … to-infuse formulation of the antibiotic vancomycin for the treatment …
-
FDA Action Alert: GSK, Alnylam, Sanofi and More
10 Mar 2025 21:08 GMT
… this month is for Alnylam Pharmaceuticals, which is seeking … and its cardiomyopathy manifestations.
Alnylam’s bid for label … of ATTR, according to Alnylam.
Theratechnologies Tries Again for … on GSK’s investigational antibiotic gepotidacin for the treatment …
-
The findings from Alnylam’s highly anticipated readout
24 Jun 2024 15:32 GMT
… On top of today’s Alnylam news, we have Congress … phage therapy.
Alnylam’s highly anticipated readout
Alnylam this morning … interest in research dwindled after antibiotics took off.
Smith points … many advantages phages have over antibiotics — such as low …
-
Alnylam’s amyloidosis drug heads latest crop of CHMP approvals
30 Jul 2018 11:27 GMT
… ahead of the weekend, including Alnylam’s patisiran for hereditary transthyretin … the first product approval for Alnylam, an RNA interference specialist which … Xerava (eravacycline), a new fluorocycline antibiotic for complicated intra-abdominal infections …
-
AGN's Superbug Antibiotic Gets FDA Nod, AFMD Soars, Boxed Warning For Ocaliva
02 Feb 2018 03:15 GMT
… and CD30-Positive Lymphomas; Alnylam's upcoming regulatory … s expanded label for superbug antibiotic AVYCAZ; Boxed Warning for … .85, up 39.62%.
Alnylam Pharmaceuticals Inc.'s (ALNY … #39;s (AGN) superbug antibiotic AVYCAZ for yet another indication …
-
Global Biodefense Market 2020 Emerging Trends, Share, Opportunities, COVID-19 Impact Analysis and Forecast-2026
30 Jun 2020 05:18 GMT
… by Product (Vaccines, Detection Devices, Antibiotics, Masks)” New Document to its …
Achaogen, Inc.
Alexeter Technologies LLC
Alnylam Pharmaceuticals, Inc.
Altimmune, Inc.
Bavarian …
-
Sickle Cell Disease Market is Predicted to Exhibit Remarkable Growth at a CAGR of 22.1% During the Forecast Period (2025–2034) Across 6MM, Owing to the Increasing Prevalence, Awareness, and Advancements in Gene Therapies | DelveInsight
03 Dec 2025 18:00 GMT
… supplements, and broad-spectrum antibiotics to manage complications. Established … companies, including Centessa Pharmaceuticals, Alnylam Pharmaceuticals, ASC Therapeutics, … , Roche, Chugai, Sanofi, Alnylam Pharmaceuticals, Pfizer, Genentech, BioMarin …
-
Rx Rundown: Novartis, Eli Lilly, GSK and more
01 Nov 2025 18:58 GMT
… after a patient was hospitalized.
Alnylam Pharmaceuticals said its drug Amvuttra … .
Sandoz told government bodies that antibiotics must cost more than M … in order to protect local antibiotics manufacturing from a flood of …
-
Regeneron Announces Positive Results from Phase 3 Trial in Generalized Myasthenia Gravis
26 Aug 2025 11:00 GMT
… an initial agreement with Alnylam Pharmaceuticals, Inc. In … cemdisiran as a monotherapy, Alnylam is entitled to receive … You should also receive antibiotics.
Meningococcal vaccines reduce the … and the agreement with Alnylam Pharmaceuticals, Inc. referenced in …
-
50 Over 50: Innovation
30 Jul 2025 10:42 GMT
… Greenstreet
63 | CEO, Alnylam Pharmaceuticals
courtesy Yvonne Greenstreet
… . At the Nasdaq-traded Alnylam Pharmaceuticals (market cap: … , the Massachusetts-based Alnylam has earned FDA approval … they practice medicine,’ reducing antibiotic use by over 50%,” …